| scholarly article | Q13442814 |
| P2093 | author name string | Evans G | |
| Baglin T | |||
| Luddington R | |||
| P2860 | cites work | Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention | Q40844377 |
| Clinical experience with the use of clotting factor concentrates in oral anticoagulation reversal | Q45856224 | ||
| Management of warfarin (coumarin) overdose | Q47855451 | ||
| Optimal oral anticoagulant therapy in patients with mechanical heart valves. | Q53374247 | ||
| Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. | Q53389030 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 998-1001 | |
| P577 | publication date | 2001-12-01 | |
| P1433 | published in | British Journal of Haematology | Q4970200 |
| P1476 | title | Beriplex P/N reverses severe warfarin-induced overanticoagulation immediately and completely in patients presenting with major bleeding | |
| P478 | volume | 115 |
| Q83232969 | 7 Procoagulators |
| Q50140400 | A Retrospective Propensity Score-Matched Early Thromboembolic Event Analysis of Prothrombin Complex Concentrate vs Fresh Frozen Plasma for Warfarin Reversal Prior to Emergency Neurosurgical Procedures |
| Q33735132 | Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy |
| Q36366940 | An observational, prospective, two-cohort comparison of a fixed versus variable dosing strategy of prothrombin complex concentrate to counteract vitamin K antagonists in 240 bleeding emergencies |
| Q37210021 | Bench-to-bedside review: Optimising emergency reversal of vitamin K antagonists in severe haemorrhage - from theory to practice |
| Q30234372 | Benefits and harms of 4-factor prothrombin complex concentrate for reversal of vitamin K antagonist associated bleeding: a systematic review and meta-analysis |
| Q48582670 | Beriplex P/N: an alternative to fresh frozen plasma in severe haemorrhage |
| Q46217099 | Bleeding risk and perioperative management of patients anticoagulated with vitamin K antagnosists |
| Q48892781 | Brodifacoum Inhalation and its Clinical Manifestations in a 21-Year-Old Caucasian Man. |
| Q93092195 | Calibrated Automated Thrombinography (CAT), a Tool to Identify Patients at Risk of Bleeding during Anticoagulant Therapy: A Systematic Review |
| Q34659834 | Coagulation factor concentrates: past, present, and future. |
| Q37867279 | Controversies of anticoagulation reversal in life-threatening bleeds |
| Q42173036 | Emergency correction of coagulation before major surgery in two elderly patients on oral anticoagulation |
| Q34626482 | Emergency reversal of anticoagulation with a three-factor prothrombin complex concentrate in patients with intracranial haemorrhage |
| Q45483161 | Emergency reversal of anticoagulation with vitamin K antagonists with 3-factor prothrombin complex concentrates in patients with major bleeding. |
| Q46727963 | Emergency warfarin reversal with prothrombin complex concentrates: UK wide study |
| Q43724849 | Experience on using prothrombin complex concentrate in urgent warfarin reversal: an Iranian survey. |
| Q38197728 | Four factor prothrombin complex concentrate (human): review of the pharmacology and clinical application for vitamin K antagonist reversal |
| Q34484090 | Guidelines on oral anticoagulation (warfarin): third edition--2005 update |
| Q36872784 | Guidelines on the insertion and management of central venous access devices in adults |
| Q51007921 | Intracerebral haemorrhage, prosthetic heart valve and anticoagulation. |
| Q33405392 | Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P/N): a pharmacovigilance study |
| Q51788589 | Management of anticoagulation in hip fractures: A pragmatic approach. |
| Q59391854 | Management of bleeding in patients on antithrombotics: maintaining the balance between thrombosis and hemorrhage |
| Q36684043 | Pharmacologic reversal of warfarin-associated coagulopathy in geriatric patients with hip fractures: a retrospective study of thromboembolic events, postoperative complications, and time to surgery |
| Q38182963 | Prothrombin complex concentrate |
| Q28265484 | Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial |
| Q21195016 | Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospital |
| Q45065534 | Prothrombin complex concentrate (Beriplex P/N). |
| Q37897816 | Prothrombin complex concentrate for critical bleeding |
| Q38002605 | Prothrombin complex concentrate for the urgent reversal of warfarin. Assessment of a standard dosing protocol |
| Q33612839 | Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding |
| Q43180952 | Prothrombin complex concentrate vs fresh frozen plasma for reversal of dilutional coagulopathy in a porcine trauma model |
| Q37646452 | Prothrombin complex concentrates for oral anticoagulant therapy-related intracranial hemorrhage: a review of the literature |
| Q34003474 | Prothrombin complex concentrates: an update |
| Q38065635 | Rapid Warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. |
| Q37306733 | Real world usage of PCC to "rapidly" correct warfarin induced coagulopathy |
| Q37209117 | Recommendations for the transfusion of plasma and platelets |
| Q42096335 | Recommendations for the use of antithrombin concentrates and prothrombin complex concentrates |
| Q55503175 | Retroperitoneal haemorrhage during warfarin therapy. |
| Q35608280 | Reversal of warfarin-induced hemorrhage in the emergency department |
| Q38937992 | Safety and Effectiveness of Factor VIII Inhibitor Bypassing Activity (FEIBA) and Fresh Frozen Plasma in Oral Anticoagulant-Associated Intracranial Hemorrhage: A Retrospective Analysis |
| Q36945970 | Safety of human plasma-derived clotting factor products and their role in haemostasis in patients with haemophilia: meeting report |
| Q38915687 | The epidemic of pre-injury oral antiplatelet and anticoagulant use. |
| Q36589312 | Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms. |
| Q48030520 | Use of Confidex to control perioperative bleeding in pediatric heart surgery: prospective cohort study. |
| Q34986856 | Use of Prothrombin Complex Concentrate for Vitamin K Antagonist Reversal before Surgical Treatment of Intracranial Hemorrhage |
| Q35194837 | Use of prothrombin complex concentrate in warfarin anticoagulation reversal in the emergency department: a quality improvement study of administration delays |
| Q24672566 | Warfarin reversal |
| Q37189939 | Warfarin-induced bleeding complications - clinical presentation and therapeutic options |
| Q37189941 | Warfarin-reversal: results of a phase III study with pasteurised, nanofiltrated prothrombin complex concentrate |
Search more.